Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-80.34%
operating margin TTM
-101.72%
revenue TTM
226.70 Million
revenue per share TTM
0.75$
valuation ratios | |
|---|---|
| pe ratio | -3.34 |
| peg ratio | -0.03 |
| price to book ratio | 4.10 |
| price to sales ratio | 2.65 |
| enterprise value multiple | -0.38 |
| price fair value | 4.10 |
profitability ratios | |
|---|---|
| gross profit margin | 37.08% |
| operating profit margin | -101.72% |
| pretax profit margin | -79.84% |
| net profit margin | -80.34% |
| return on assets | -16.43% |
| return on equity | -247.63% |
| return on capital employed | -21.74% |
liquidity ratios | |
|---|---|
| current ratio | 10.64 |
| quick ratio | 9.12 |
| cash ratio | 8.24 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 184.96 |
| operating cycle | 251.90 |
| days of payables outstanding | 49.33 |
| cash conversion cycle | 202.57 |
| receivables turnover | 5.45 |
| payables turnover | 7.40 |
| inventory turnover | 1.97 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.82 |
| debt equity ratio | 6.15 |
| long term debt to capitalization | 0.86 |
| total debt to capitalization | 0.86 |
| interest coverage | -46.82 |
| cash flow to debt ratio | -0.17 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.41 |
| cash per share | 0.90 |
| operating cash flow per share | -0.36 |
| free cash flow operating cash flow ratio | 1.11 |
| cash flow coverage ratios | -0.17 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -8.75 |
Frequently Asked Questions
When was the last time Pacific Biosciences of California, Inc. (NASDAQ:PACB) reported earnings?
Pacific Biosciences of California, Inc. (PACB) published its most recent earnings results on 07-05-2026.
What is Pacific Biosciences of California, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Pacific Biosciences of California, Inc. (NASDAQ:PACB)'s trailing twelve months ROE is -247.63%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Pacific Biosciences of California, Inc. (PACB) currently has a ROA of -16.43%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PACB's net profit margin stand at?
PACB reported a profit margin of -80.34% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PACB's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 10.64 in the most recent quarter. The quick ratio stood at 9.12, with a Debt/Eq ratio of 6.15.